Raymond Woo's most recent trade in Ceribell Inc. was a trade of 11,112 Common Stock done at an average price of $12.3 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.28 per share. | 01 Dec 2025 | 11,112 | 167,704 | - | 12.3 | 136,455 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Dec 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 6,615 | 52,138 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Dec 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 3,025 | 47,821 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 01 Dec 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 1,472 | 15,746 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.28 per share. | 11 Nov 2025 | 11,112 | 167,704 | - | 12.3 | 136,455 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 6,615 | 58,753 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 11 Nov 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 3,025 | 50,846 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 11 Nov 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 11 Nov 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2025 | 1,472 | 17,218 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.54 per share. | 03 Oct 2025 | 11,112 | 167,704 | - | 12.5 | 139,344 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 6,615 | 65,368 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 03 Oct 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 3,025 | 53,871 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 03 Oct 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 03 Oct 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 1,472 | 18,690 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.11 per share. | 04 Sep 2025 | 11,112 | 167,704 | - | 12.1 | 134,566 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 6,615 | 71,983 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 04 Sep 2025 | 6,615 | 178,816 | - | 4.7 | 31,091 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 3,025 | 56,896 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 04 Sep 2025 | 3,025 | 172,201 | - | 4.7 | 14,218 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 04 Sep 2025 | 1,472 | 169,176 | - | 2.2 | 3,297 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 1,472 | 20,162 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 20,000 | 21,634 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 02 Sep 2025 | 20,000 | 167,704 | - | 2.2 | 44,800 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.58 per share. | 25 Aug 2025 | 687 | 147,704 | - | 11.6 | 7,955 | Common Stock |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 51,159 | 51,159 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc | Raymond Woo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 30,695 | 148,391 | - | 0 | Common Stock | |
| Oruka Therapeutics Inc | Raymond Woosley L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| DoubleLine Opportunistic Credit Fund | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 5,291 | 0 | - | - | Common Shares | |
| Doubleline Income Soln Fund | Raymond Woolson B. | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 3,659 | 0 | - | - | Common Shares | |
| DoubleLine Yield Opportunities Fund | B. Raymond Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,776 | 0 | - | - | Common Shares | |
| Oruka Therapeutics Inc | Raymond L. Woosley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Westwood Holdings Grp Inc | Raymond E. Wooldridge | Director | Purchase of securities on an exchange or from another person at price $ 17.49 per share. | 01 Nov 2021 | 10,000 | 77,597 (0%) | 0% | 17.5 | 174,887 | common stock |
| DoubleLine Yield Opportunities Fund | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 358 | 1,464 | - | - | Common Shares | |
| DoubleLine Yield Opportunities Fund | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 354 | 1,087 | - | - | Common Shares | |
| Westwood Holdings Grp Inc | Raymond E. Wooldridge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 5,609 | 67,597 (0%) | 0% | 0 | common stock | |
| DoubleLine Yield Opportunities Fund | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 356 | 720 | - | - | Common Shares | |
| Oruka Therapeutics Inc | Raymond L. Woosley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| DoubleLine Yield Opportunities Fund | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 04 Jan 2021 | 358 | 358 | - | - | Common Shares |